Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Pharmaceuticals 2011, 4(10), 1281-1292; doi:10.3390/ph4101281
Article

Degradable Cross-Linked Nanoassemblies as Drug Carriers for Heat Shock Protein 90 Inhibitor 17-N-Allylamino-17-demethoxy-geldanamycin

,  and *
Received: 8 August 2011; in revised form: 7 September 2011 / Accepted: 19 September 2011 / Published: 26 September 2011
(This article belongs to the Special Issue Hsp90 Inhibitors)
View Full-Text   |   Download PDF [610 KB, uploaded 26 September 2011]
Abstract: Cross-linked nanoassemblies (CNAs) with a degradable core were prepared for sustained release of 17-N-allylamino-17-demethoxygeldanamycin (17-AAG), a potent inhibitor of heat shock protein 90 (HSP90). The particle size of CNAs ranged between 100 and 250 nm, which changed depending on the cross-linking yields and drug entrapment method. CNAs with a 1% cross-linking yield entrapped 17-AAG in aqueous solutions, yet degraded in 3 hrs. CNAs entrapped 5.2 weight% of 17-AAG as the cross-linking yield increased to 10%, retaining more than 80% of particles for 24 hrs. CNAs with drugs entrapped after the cross-linking reactions were 100 nm and remained stable in both pH 7.4 and 5.0, corresponding to the physiological, tumoral, and intracellular environments. Drug was completely released from CNAs in 48 hrs, which would potentially maximize drug delivery and release efficiency within tumor tissues. Drug release patterns were not negatively affected by changing the cross-linking yields of CNAs. CNAs entrapping 17-AAG suppressed the growth of human non-small cell lung cancer A549 cells as equally effective as free drugs. The results demonstrated that CNAs would be a promising formulation that can be used in aqueous solutions for controlled delivery and release of 17-AAG.
Keywords: drug delivery; controlled drug release; nanoassemblies; heat shock protein 90; cancer chemotherapy drug delivery; controlled drug release; nanoassemblies; heat shock protein 90; cancer chemotherapy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Ponta, A.; Akter, S.; Bae, Y. Degradable Cross-Linked Nanoassemblies as Drug Carriers for Heat Shock Protein 90 Inhibitor 17-N-Allylamino-17-demethoxy-geldanamycin. Pharmaceuticals 2011, 4, 1281-1292.

AMA Style

Ponta A, Akter S, Bae Y. Degradable Cross-Linked Nanoassemblies as Drug Carriers for Heat Shock Protein 90 Inhibitor 17-N-Allylamino-17-demethoxy-geldanamycin. Pharmaceuticals. 2011; 4(10):1281-1292.

Chicago/Turabian Style

Ponta, Andrei; Akter, Shanjida; Bae, Younsoo. 2011. "Degradable Cross-Linked Nanoassemblies as Drug Carriers for Heat Shock Protein 90 Inhibitor 17-N-Allylamino-17-demethoxy-geldanamycin." Pharmaceuticals 4, no. 10: 1281-1292.



Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert